• S1 Episode 6: Non-Muscle Invasive Bladder Cancer Innovations

  • Nov 8 2022
  • Length: 20 mins
  • Podcast

S1 Episode 6: Non-Muscle Invasive Bladder Cancer Innovations

Listen for free

View show details

  • Summary

  • Drs Cheryl Lee and Sima Porten discuss urinary biomarkers, enhanced cystoscopy, treatments on the horizon, and communication with team members from the cytopathology lab using the PARIS classification.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970416). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Paris System for Reporting Urinary Cytopathology https://paris.soc.wisc.edu/index.htm

    Bladder Cancer Biomarkers: Optimal Utilization for Diagnosis and Recurrence https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/93133-bladder-cancer-biomarkers-optimal-utilization-for-diagnosis-and-recurrence-everyday-urology-full-text-article.html

    Diagnostic Performance of Oncuria™, a Urinalysis Test for Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025333/

    Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer https://www.frontiersin.org/articles/10.3389/fimmu.2020.615091/full
    Show more Show less
Show more Show less

What listeners say about S1 Episode 6: Non-Muscle Invasive Bladder Cancer Innovations

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available